Soleus Capital Master Fund, L.P. 13D and 13G filings for Organogenesis Holdings Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-11 4:00 pm Purchase |
2024-12-31 | 13G | Organogenesis Holdings Inc. ORGO |
Soleus Capital Master Fund, L.P. | 12,484,876 9.900% |
645,000 (+5.45%) |
Filing |
| 2024-11-14 3:35 pm Purchase |
2024-09-30 | 13G | Organogenesis Holdings Inc. ORGO |
Soleus Capital Master Fund, L.P. | 11,839,876 8.900% |
2,876,876 (+32.10%) |
Filing |
| 2024-02-02 09:54 am Purchase |
2023-12-31 | 13G | Organogenesis Holdings Inc. ORGO |
Soleus Capital Master Fund, L.P. | 8,963,000 6.800% |
1,599,937 (+21.73%) |
Filing |
| 2023-02-14 08:22 am Purchase |
2022-12-31 | 13G | Organogenesis Holdings Inc. ORGO |
Soleus Capital Master Fund, L.P. | 7,363,063 5.600% |
737,000 (+11.12%) |
Filing |
| 2022-10-13 5:01 pm Purchase |
2022-10-11 | 13G | Organogenesis Holdings Inc. ORGO |
Soleus Capital Master Fund, L.P. | 6,626,063 5.100% |
6,626,063 (New Position) |
Filing |